Source link : https://www.newshealth.biz/health-news/obesity-medications-who-needs-priority-access/
When new medications are so effective that physicians refer to them as “gamechangers,” it tends to generate a lot of interest. In the case of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) such as semaglutide and tirzepatide, the demand was so intense that shortages resulted. Supriya Rao, MD “They work really well, and the amount […]
Author : News Health
Publish date : 2025-01-23 17:35:40
Copyright for syndicated content belongs to the linked Source.